| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 127.58B | 123.72B | 121.87B | 121.14B | 119.63B |
| Gross Profit | 62.88B | 57.33B | 55.18B | 52.08B | 51.33B |
| EBITDA | 50.74B | 47.76B | 48.39B | 45.85B | 44.38B |
| Net Income | 23.31B | 19.11B | 17.74B | 15.81B | 14.58B |
Balance Sheet | |||||
| Total Assets | 407.76B | 403.41B | 405.41B | 399.06B | 378.17B |
| Cash, Cash Equivalents and Short-Term Investments | 77.80B | 114.52B | 114.32B | 107.91B | 85.91B |
| Total Debt | 32.36B | 55.15B | 65.81B | 73.55B | 85.35B |
| Total Liabilities | 100.72B | 119.24B | 133.43B | 142.24B | 135.09B |
| Stockholders Equity | 303.55B | 281.71B | 270.22B | 255.42B | 241.99B |
Cash Flow | |||||
| Free Cash Flow | 6.67B | 20.80B | 27.03B | 40.22B | 28.13B |
| Operating Cash Flow | 53.67B | 42.38B | 42.40B | 57.63B | 36.51B |
| Investing Cash Flow | -76.46B | -25.78B | -15.38B | -16.87B | -7.74B |
| Financing Cash Flow | -32.28B | -16.74B | -21.10B | -19.42B | -16.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥911.60B | 17.88 | 5.45% | 1.30% | 4.46% | 21.50% | |
70 Outperform | ¥16.14B | 14.08 | ― | 3.04% | -3.59% | -29.46% | |
69 Neutral | ¥705.18B | 12.22 | 6.38% | 1.03% | 4.87% | 24.35% | |
63 Neutral | ¥1.05T | 43.59 | 7.76% | 1.67% | 3.12% | 21.97% | |
62 Neutral | ¥27.03B | 22.38 | ― | 2.17% | 0.48% | 103.08% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
43 Neutral | ¥558.72B | 133.72 | -2.45% | 1.40% | 0.20% | ― |